Immunoassays from discovery to the clinic

Cut project times and boost productivity

Gyros immunoassay platform in action at:

Quotient Bioresearch

RecipharmCobra Biologics

Rentschler Biotechnologie

ProBioGen

MPI Research

Novo Nordisk

Pfizer

Morphotek

Roche

QPS

Thrombogenics

York Bioanalytical Solutions

Covance

Syrinx Bioanalytics

Radix BioSolutions

Lonza

Rudbeck Laboratory

NovImmune

Millipore

GE Healthcare

GlaxoSmithKline

ICON

Worldwide Clinical Trials

Ablynx

Bayer Schering Pharma

Biogen Idec

Bristol-Myers Squibb

Huntingdon Life Sciences

PhaseBio Pharmaceuticals

National Research Centre for the Working Environment (AMI)

National Veterinary Institute

Novartis

MerckSerono

Amgen

MedImmune

Merck

AstraZeneca

A much-simplified way of working

Dr. A. Hagman, AstraZeneca

Gyros news

Uppsala, Sweden, 7 December 2011

Gyros expands commercial reach in Asia

Uppsala, Sweden, 20 October 2011

Gyros announces changes to its management team

Uppsala, Sweden, 11 October 2011

Gyros introduces new application to monitor anti-drug antibodies during development of biotherapeutics

Featured research

Minimising Volume, Maximising Returns

European Pharmaceutical Review, Discovery Technology, Spring 2010.

S. Hannam, J. Allinson and R. Briggs.

Read paper

Upcoming events

21-23 May 2012 - San Diego, California

AAPS National Biotechnology Conference 2012

Immunoassays from discovery to the clinic

Gyros immunoassay platform in action at:

Gyros news

Featured research

Minimising Volume, Maximising Returns

Upcoming events

Immunoassays in the biotherapeutic workflow

Gyros immunoassay platform

Develop and run immunoassays at nanoliter scale:

Ready to use on Gyrolab xP workstation

Designed for use with Gyrolab CDs

E-mail:
Password:
Keep me logged in